SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001140361-21-009381
Filing Date
2021-03-22
Accepted
2021-03-19 18:19:01
Documents
17

Document Format Files

Seq Description Document Type Size
1 424B4 nt10015006x17_424b4.htm 424B4 2505352
2 logo_gainthera.jpg GRAPHIC 67825
3 nt10015006x11_logo.jpg GRAPHIC 56921
4 nt10015006x17_graphic1.jpg GRAPHIC 318409
5 nt10015006x17_graphic2.jpg GRAPHIC 195913
6 nt10015006x17_graphic3.jpg GRAPHIC 122515
7 nt10015006x17_graphic4.jpg GRAPHIC 245744
8 nt10015006x17_graphic5.jpg GRAPHIC 124947
9 nt10015006x17_graphic6.jpg GRAPHIC 86298
10 nt10015006x17_graphic7.jpg GRAPHIC 202743
11 nt10015006x17_graphic8.jpg GRAPHIC 244171
12 nt10015006x17_graphic8x1.jpg GRAPHIC 170871
13 nt10015006x17_graphic9.jpg GRAPHIC 99981
14 nt10015006x17_graphic12.jpg GRAPHIC 74773
15 nt10015006x17_graphic13.jpg GRAPHIC 86017
16 nt10015006x17_graphic14.jpg GRAPHIC 204955
17 nt10015006x17_trichart1.jpg GRAPHIC 125844
  Complete submission text file 0001140361-21-009381.txt   5847638
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-253303 | Film No.: 21759366
SIC: 2834 Pharmaceutical Preparations